NVCT · Categories · Form 4

NVCT - SEC Form 4 insider transactions

Nuvectis Pharma Inc. (NVCT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for NVCT

• 20d
  Vice President, Finance Carson Michael J. was granted 30,000 shares, increasing direct ownership by 15% to 230,118 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 74d
  Director Hoberman Kenneth was granted 35,000 shares, increasing direct ownership by 26% to 168,140 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 74d
  Director Oliviero James F Iii was granted 35,000 shares, increasing direct ownership by 40% to 122,828 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 74d
  Director Sanchez Juan was granted 35,000 shares, increasing direct ownership by 45% to 113,380 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 74d
  Director Kaplan Matthew L. was granted 35,000 shares, increasing direct ownership by 28% to 159,760 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 228d
  Chief Dev. & Ops. Officer Shemesh Shay was granted 150,000 shares, increasing direct ownership by 9% to 1,793,068 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 228d
  Chairman & CEO Bentsur Ron was granted 150,000 shares, increasing direct ownership by 4% to 3,675,924 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 228d
  Chief Science & Business Off Poradosu Enrique was granted 150,000 shares, increasing direct ownership by 9% to 1,806,319 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 228d
  Vice President, Finance Carson Michael J. was granted 61,200 shares, increasing direct ownership by 44% to 200,118 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 298d
  Director Sanchez Juan was granted 30,000 shares, increasing direct ownership by 85% to 65,150 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 439d
  Director Kaplan Matthew L. was granted 30,000 shares, increasing direct ownership by 36% to 113,760 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 439d
  Director Oliviero James F Iii was granted 30,000 shares, increasing direct ownership by 52% to 87,828 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 439d
  Director Hoberman Kenneth was granted 30,000 shares, increasing direct ownership by 29% to 133,140 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 599d
  Chief Dev. & Ops. Officer Shemesh Shay was granted 150,000 shares, increasing direct ownership by 10% to 1,643,068 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 599d
  Chief Science & Business Off Poradosu Enrique was granted 150,000 shares, increasing direct ownership by 10% to 1,656,319 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 599d
  Vice President, Finance Carson Michael J. was granted 51,000 shares, increasing direct ownership by 58% to 138,918 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 599d
  Chairman & CEO Bentsur Ron was granted 250,000 shares, increasing direct ownership by 8% to 3,520,924 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 655d
  Vice President, Finance Carson Michael J. sold $22,478 worth of shares (2,755 units at $8.16) and was granted 63,373 shares, increasing direct ownership by 222% to 87,918 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 803d
  Director Kaplan Matthew L. was granted 30,000 shares, increasing direct ownership by 56% to 83,760 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 803d
  Director Hoberman Kenneth was granted 30,000 shares, increasing direct ownership by 41% to 103,140 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 803d
  Director Oliviero James F Iii was granted 30,000 shares, increasing direct ownership by 108% to 57,828 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 963d
  Poradosu Enrique was granted 130,000 shares, increasing direct ownership by 9% to 1,503,819 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 963d
  Shemesh Shay was granted 130,000 shares, increasing direct ownership by 10% to 1,491,955 units (SEC Form 4)

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1105d
  SEC Form 4: Bentsur Ron bought $5,112 worth of shares (350 units at $14.61), increasing direct ownership by 0.01% to 3,232,544 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1110d
  SEC Form 4: Bentsur Ron bought $4,418 worth of shares (300 units at $14.73), increasing direct ownership by 0.01% to 3,232,194 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1120d
  SEC Form 4: Mosseri Marlio Charles bought $11,937 worth of shares (860 units at $13.88), increasing direct ownership by 0.03% to 2,595,000 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1121d
  SEC Form 4: Mosseri Marlio Charles bought $35,943 worth of shares (2,584 units at $13.91), increasing direct ownership by 0.10% to 2,594,140 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1124d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1125d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1128d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1128d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1132d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1132d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1133d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1134d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1139d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1140d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1142d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1145d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1145d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1146d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1155d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1155d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1156d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1159d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1160d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1162d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1162d
  SEC Form 4 filed by Oliviero James F Iii

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1162d
  SEC Form 4 filed by Kaplan Matthew L.

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1162d
  SEC Form 4 filed by Hoberman Kenneth

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1166d
  SEC Form 4 filed by Mosseri Marlio Charles

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1174d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1181d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1187d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1195d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1246d
  SEC Form 4 filed by Poradosu Enrique

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1247d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1251d
  SEC Form 4 filed by Bentsur Ron

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1252d
  SEC Form 4 filed by Shemesh Shay

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)
• 1257d
  SEC Form 4: Shemesh Shay bought $7,176 worth of shares (670 units at $10.71), increasing direct ownership by 0.05% to 1,361,535 units

  4 - Nuvectis Pharma, Inc. (0001875558) (Issuer)

Other NVCT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends